Cite
HARVARD Citation
Swain, S. et al. (2013). Cardiac Tolerability of Pertuzumab Plus Trastuzumab Plus Docetaxel in Patients With HER2‐Positive Metastatic Breast Cancer in CLEOPATRA: A Randomized, Double‐Blind, Placebo‐Controlled Phase III Study. Oncologist. pp. 257-264. [Online].